Article
Implications Of CRISPR Dispute On Licensees
A decision in May from the Federal Circuit Court of Appeals has extended the long-standing and well-publicized dispute over inventorship of use of CRISPR-Cas9 technology in eukaryotic cells.
Crowell & Moring LLP